Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›AbbVie Limited

Medicines register · Ireland

AbbVie Limited — licensed medicines

19 medicines held by AbbVie Limited on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 07 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Acular 0.5% w/v Eye Drops, solution PA1824/015/001

Ketorolac trometamol

Marketed

Alphagan 0.2% w/v (2 mg/ml) eye drops, solution PA1824/007/001

Brimonidine tartrate

Marketed

BOTOX 100 Allergan Units powder for solution for injection PA1824/017/001

Botulinum Toxin Type A

Marketed

BOTOX 200 Allergan Units powder for solution for injection PA1824/017/003

Botulinum Toxin Type A

Marketed

BOTOX 50 Allergan Units powder for solution for injection PA1824/017/002

Botulinum Toxin Type A

Marketed

Celluvisc 0.5 % w/v eye drops solution, unit dose PA1824/016/002

Carmellose sodium

Marketed

Celluvisc 1% w/v Eye drops, solution, unit dose PA1824/016/001

Carmellose sodium

Marketed

Combigan 2 mg/ml + 5 mg/ml eye drops, solution PA1824/019/001

Brimonidine tartrate, Timolol Maleate

Not marketed

Duodopa 20 mg/ml + 5 mg/ml intestinal gel PA1824/002/001

Levodopa, Carbidopa

Marketed

EXOCIN (Ofloxacin) 0.3% w/v Eye Drops Solution PA1824/014/001

Ofloxacin

Marketed

FML 0.1% w/v Eye Drops Suspension PA1824/008/001

Fluorometholone

Not marketed

Pred Forte 1% w/v, Eye Drops Suspension PA1824/010/001

Prednisolone acetate

Marketed

Produodopa 240 mg/ml + 12 mg/ml solution for infusion PA1824/002/003

Foslevodopa, Foscarbidopa

Marketed

Relestat, 0.5 mg/ml, eye drops, solution PA1824/018/001

Epinastine hydrochloride

Not marketed

Sevorane 100% v/v Inhalation Gas PA1824/004/001

Sevoflurane

Marketed

VISTABEL, 4 Allergan Units/0.1ml, Powder for solution for injection PA1824/020/001

Botulinum Toxin Type A

Marketed

Zemplar 1 microgram capsules, soft PA1824/005/001

Paricalcitol

Marketed

Zemplar 2 micrograms capsules, soft PA1824/005/002

Paricalcitol

Marketed

Zemplar 5 micrograms/ml solution for injection PA1824/005/004

Paricalcitol

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 7 October 2026. https://priyalifescience.com/medicines/company/abbvie-limited

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.